| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op | Sale+OE | 1,310 | $370.19 | $484,943.40 | -3.8% | → |
| 2024-04-23 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 5,318 | $370.66 | $1,971,160.31 | -89.9% | → |
| 2024-04-23 | LEVY ALAN J | Director | Sale+OE | 2,000 | $370.70 | $741,397.60 | -7.3% | → |
| 2024-03-15 | Widman Fredrik | VP Corporate Controller | Sale+OE | 5,041 | $397.07 | $2,001,629.87 | -93.9% | → |
| 2024-03-11 | Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell | 392 | $391.09 | $153,307.28 | -14.5% | → |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op | Sale+OE | 20,625 | $393.74 | $8,120,872.41 | -13.7% | → |
| 2024-03-07 | Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell | 588 | $393.35 | $231,291.76 | -10.6% | → |
| 2024-03-01 | Curet Myriam | EVP & Chief Medical Officer | Sell | 1,605 | $383.48 | $615,485.40 | -84.3% | → |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S | Sale+OE | 108,790 | $385.08 | $41,893,066.00 | -26.1% | → |
| 2024-02-27 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 843 | $386.46 | $325,785.78 | -73.9% | → |
| 2024-02-16 | Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell | 92 | $380.10 | $34,968.88 | -4.0% | → |
| 2024-02-13 | Brosius Mark | SVP & Chief Mfg and Supply Cha | Sell | 60 | $380.80 | $22,847.85 | -3.5% | → |
| 2024-02-12 | Curet Myriam | EVP & Chief Medical Officer | Sale+OE | 481 | $386.09 | $185,709.29 | -61.7% | → |
| 2024-02-07 | Rosa David J. | President | Sale+OE | 36,020 | $389.28 | $14,021,993.65 | -9.0% | → |